education
Download App
Indonesia
search
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Country
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Other Services
Education
Download App
Country
Indonesia
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
Account
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Iklan
Iklan
MIMS home
Drugs
Info
Lagesil
Lagesil
Manufacturer:
Lapi
SELECT
Concise Prescribing Info
Bahasa Concise Prescribing Info
Concise Prescribing Info
Bahasa Concise Prescribing Info
Concise Prescribing Info
Contents
Per tab/5 mL susp
Simethicone 50 mg, Mg hydroxide 250 mg, Al hydroxide 250 mg
Indications/Uses
Gastric hyperacidity, peptic ulcer, accumulation of gas in GIT.
Dosage/Direction for Use
Tab
Adult
1 tab.
Childn
½ tab. To be taken 3-4 times daily.
Susp
Adult & childn >12 yr
1-2 tsp 3-4 times daily.
Administration
Should be taken on an empty stomach: Take 1-3 hr after meals & before bedtime.
Contraindications
Renal failure.
Special Precautions
Renal insufficiency.
Adverse Reactions
Rarely, constipation, diarrhea. Hypophosphatemia (prolonged use).
View
ADR Reporting Link
Drug Interactions
Affects absorption of Fe, tetracyclines, digoxin, INH, warfarin, H
2
-receptor antagonists.
MIMS Class
Antacids, Antireflux Agents & Antiulcerants
ATC Classification
A02AF02 - ordinary salt combinations and antiflatulents ; Belongs to the class of antacids with antiflatulents.
Regulatory Classification
T
Presentation/Packing
Form
Lagesil oral susp
Packing/Price
170 mL x 1's (Rp19,000/botol)
Form
Lagesil tab
Packing/Price
100's (Rp42,500/pak)
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan
Daftar Gratis untuk melanjutkan membaca
Lanjutkan dengan Google
Daftar dengan email
Sudah punya akun?
Masuk
Daftar Gratis untuk melanjutkan membaca
Lanjutkan dengan Google
Daftar dengan email
Sudah punya akun?
Masuk